Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
-11.6 %
$ 53.7 M
Market Cap
-0.45
P/E
KPTI - TOTAL RECEIVABLES
Total Receivables KPTI - Karyopharm Therapeutics Inc.
30.8 M
LAST VALUE
-19.17%
2 YEAR CAGR
31.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR